Celularity Inc.: shareholders and insiders

CELUNASDAQHealthcare · Pharmaceutical Preparations

Price

$0.62

November 16, 2026Market cap $20M

What Ploutos Investor adds for Celularity

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 51% since Oct 20, 2026, when the 10-Q these figures come from was filed ($1.26 then, $0.62 on Nov 16, 2026). The figures date from before that move.10-Q
  • A figure that did not match the numbers it is built from has been left out.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

6 Form 4s

Sorry, we do not have enough data

for purchases and sales by Celularity's insiders

Why?

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%2 On a 13DSep 28, 2026 Latest filing
  • Dragasac Limitedwith 3 more personsClass A Common Stock, par value $0.0001 per share
    Share of class41.0%
  • Philip & Daniele Barach Family Trustwith 2 more personsClass A Common Stock, Par Value $0.0001 Per Share
    Share of class29.0%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Dragasac Limited41.0%From the filing of Jul 28, 2025

    Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Pursuant to the terms agreed upon in the binding term sheet ("Term Sheet") between the Issuer and RWI dated February 12, 2025, RWI agreed to, among other things, an extension of that certain second forbearance agreement dated as of March 13, 2024. Specifically, RWI agreed not to exercise its rights and remedies upon the occurrence of any default under the second amended and restated senior secured loan agreement dated as of January 12, 2024 until an amendment is entered into between the Issuer and RWI whereby the maturity date of the following loans is extended to February 15, 2026: (i) an initial loan in the…

    From the filing of Jul 28, 2025
  • Philip & Daniele Barach Family Trust29.0%From the filing of Sep 28, 2026

    In connection with the Financing, on September 23, 2026, the Trust and the Company entered into a Board Rights Agreement, pursuant to which the size of the Company's board of directors is to be fixed at five directors, with the Trust having the right to designate two persons to be appointed to the board of directors (the "Trust Directors"). Philip Barach, a trustee of the Trust, was appointed to the Company's board of directors as a designee of the Trust under the Board Rights Agreement on September 24, 2026. In addition, the reasonable approval of the Trust Directors must be obtained for the appointment of an independent director by the other directors, and the Company's ability spend the…

    From the filing of Sep 28, 2026
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Lincoln Alternative Strategies LLC0.00%Feb 11, 202613G/A
  • Bristol Myers Squibb1.90%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Jun 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.36% of its shares outstanding were held short, +12.9% since the report before.

Shares held short
441.8K
1.36%
Since the report before391.3K on Sep 30, 2026
+12.9%
3.7
120.7K
More days to cover thanof 4,578 US-listed companies with enough volume
43%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 1.41M
  • Nov 15, 2023: Shares held short 1.40M
  • Nov 30, 2023: Shares held short 1.23M
  • Dec 15, 2023: Shares held short 1.47M
  • Dec 29, 2023: Shares held short 1.56M
  • Jan 12, 2024: Shares held short 2.06M
  • Jan 31, 2024: Shares held short 3.28M
  • Feb 15, 2024: Shares held short 3.75M
  • Feb 29, 2024: Shares held short 466.6K
  • Mar 15, 2024: Shares held short 388.3K
  • Mar 28, 2024: Shares held short 415.8K
  • Apr 15, 2024: Shares held short 393.1K
  • Apr 30, 2024: Shares held short 595.0K
  • May 15, 2024: Shares held short 627.1K
  • May 31, 2024: Shares held short 637.6K
  • Jun 14, 2024: Shares held short 680.1K
  • Jun 28, 2024: Shares held short 698.7K
  • Jul 15, 2024: Shares held short 727.1K
  • Jul 31, 2024: Shares held short 716.2K
  • Aug 15, 2024: Shares held short 714.0K
  • Aug 30, 2024: Shares held short 694.1K
  • Sep 13, 2024: Shares held short 682.3K
  • Sep 30, 2024: Shares held short 679.2K
  • Oct 15, 2024: Shares held short 680.5K
  • Oct 31, 2024: Shares held short 743.7K
  • Nov 15, 2024: Shares held short 934.5K
  • Nov 29, 2024: Shares held short 707.7K
  • Dec 13, 2024: Shares held short 369.3K
  • Dec 31, 2024: Shares held short 395.6K
  • Jan 15, 2025: Shares held short 259.6K
  • Jan 31, 2025: Shares held short 171.7K
  • Feb 14, 2025: Shares held short 287.4K
  • Feb 28, 2025: Shares held short 1.04M
  • Mar 14, 2025: Shares held short 1.56M
  • Mar 31, 2025: Shares held short 1.59M
  • Apr 15, 2025: Shares held short 1.65M
  • Apr 30, 2025: Shares held short 1.68M
  • May 15, 2025: Shares held short 1.61M
  • May 30, 2025: Shares held short 1.48M
  • Jun 13, 2025: Shares held short 1.44M
  • Jun 30, 2025: Shares held short 1.52M
  • Jul 15, 2025: Shares held short 1.55M
  • Jul 31, 2025: Shares held short 1.68M
  • Aug 15, 2025: Shares held short 1.63M
  • Aug 29, 2025: Shares held short 1.69M
  • Sep 15, 2025: Shares held short 1.40M
  • Sep 30, 2025: Shares held short 640.1K
  • Oct 15, 2025: Shares held short 684.3K
  • Oct 31, 2025: Shares held short 630.9K
  • Nov 14, 2025: Shares held short 613.3K
  • Nov 28, 2025: Shares held short 508.0K
  • Dec 15, 2025: Shares held short 381.8K
  • Dec 31, 2025: Shares held short 483.3K
  • Jan 15, 2026: Shares held short 533.2K
  • Jan 30, 2026: Shares held short 488.6K
  • Feb 13, 2026: Shares held short 355.4K
  • Feb 27, 2026: Shares held short 309.4K
  • Mar 13, 2026: Shares held short 433.5K
  • Mar 31, 2026: Shares held short 294.6K
  • Apr 15, 2026: Shares held short 226.4K
  • Apr 30, 2026: Shares held short 275.4K
  • May 15, 2026: Shares held short 373.2K
  • May 29, 2026: Shares held short 345.3K
  • Jun 15, 2026: Shares held short 375.0K
  • Jun 30, 2026: Shares held short 413.4K
  • Jul 15, 2026: Shares held short 419.5K
  • Jul 31, 2026: Shares held short 390.8K
  • Aug 14, 2026: Shares held short 403.6K
  • Aug 31, 2026: Shares held short 1.90M
  • Sep 15, 2026: Shares held short 821.0K
  • Sep 30, 2026: Shares held short 391.3K
  • Oct 15, 2026: Shares held short 441.8K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading52.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 52.9% of the shares in the reported trades were short sales, against 58.5% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
52.9%
The 14 beforeOct 8, 2026 – Oct 27, 2026
58.5%
Change
-5.6 pts
Short sales a dayon average, of 75.9K shares
40.1K
More than atof 3,668 US-listed companies, same days
60%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 35.2%
  • Oct 9, 2026: Short sales 61.7%
  • Oct 12, 2026: Short sales 41.7%
  • Oct 13, 2026: Short sales 28.3%
  • Oct 14, 2026: Short sales 79.6%
  • Oct 15, 2026: Short sales 23.7%
  • Oct 16, 2026: Short sales 41.9%
  • Oct 19, 2026: Short sales 48.8%
  • Oct 20, 2026: Short sales 79.5%
  • Oct 21, 2026: Short sales 75.6%
  • Oct 22, 2026: Short sales 76.4%
  • Oct 23, 2026: Short sales 78%
  • Oct 26, 2026: Short sales 50.2%
  • Oct 27, 2026: Short sales 52%
  • Oct 28, 2026: Short sales 61.5%
  • Oct 29, 2026: Short sales 44.1%
  • Oct 30, 2026: Short sales 53%
  • Nov 2, 2026: Short sales 45.7%
  • Nov 3, 2026: Short sales 67.8%
  • Nov 4, 2026: Short sales 38.7%
  • Nov 5, 2026: Short sales 32.4%
  • Nov 6, 2026: Short sales 42.3%
  • Nov 9, 2026: Short sales 63.6%
  • Nov 10, 2026: Short sales 51.4%
  • Nov 11, 2026: Short sales 59%
  • Nov 12, 2026: Short sales 65.6%
  • Nov 13, 2026: Short sales 70%
  • Nov 16, 2026: Short sales 57.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

1 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%

1 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

39 Managers, Q2 2026$2.4M Value of their positions
  • Q3 2025: Managers 38
  • Q4 2025: Managers 36
  • Q1 2026: Managers 38
  • Q2 2026: Managers 39

Institutional investors by quarter

The fund managers holding CELU, quarter by quarter, from Q3 2021 to Q2 2025, 16 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 39 managers held 2.20M shares, worth $2.4M. During the quarter 5 opened a position, 4 closed one, 9 added and 4 trimmed.

The largest holders, Q2 2026

  • C V Starr
    In the quarter
  • Vanguard Capital Management
    In the quarter
  • Geode Capital Management
    In the quarter-13%
  • Citadel Advisors (Griffin)
    In the quarter
  • Vanguard Fiduciary Trust
    In the quarter
  • BlackRock
    In the quarter-40%
  • State Street
    In the quarter
  • Hrt Financial
    In the quarter+343%
  • Northern Trust
    In the quarter
  • Biltmore Family Office
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Celularity's filings show?

Who buys and sells is one part of Celularity's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CELU's shareholders

Didn't find what you were looking for?

Ask us
Have CELU's insiders bought or sold?

From Jun 23, 2026 to Sep 25, 2026 Celularity's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold CELU?

1 of the managers we track held the shares on Jun 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $100.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.